Since 20 12, stocks related to the concept of health services, including drugs and medical devices, have been sought after by investors in the secondary market. Some fund managers said that the contraction of traditional production capacity and the expansion of production capacity related to people's livelihood and health will be the general trend for a long time to come. These industries, especially medical devices and innovative drugs, will be stimulated by policy support and expanding market demand, and enterprises with great growth potential will emerge.
According to the Report on Market Prospects and Investment Planning of Health Service Industry in China, the scale of China's health service industry will be about10.65 trillion yuan in 20 13 years, while the State Council clearly pointed out that the total scale of health service industry will reach more than 8 trillion yuan in 2020, which means that the average annual growth rate of China's medical and health service industry will reach at least 2 trillion yuan in 20 14-2020. China's health service industry will usher in a long-term and sustained high prosperity, and the expansion of the market and the increase of the share of private hospitals will provide a broad development space for the development of private hospitals.